With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.
Boston Scientific posts positive data for coronary IVL catheter Read More »
Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s interventional business.
Far fewer companies are letting employees go so far in 2026 compared to 2025, but the number of people affected is trending up, especially this month, according to BioSpace tallies.
Takeda cuts send layoffs soaring in May, rising year over year Read More »
Analysts are extremely encouraged by Phase 2 trial results for Relay Therapeutics’ PI3KA inhibitor in treating vascular malformations (VM), prompting the biotech to eye a potential path to accelerated approval.
Relay doubles the bar, outpacing Novartis with a 60% response in rare disease Read More »
Nathan Frank discusses how the insurer is using AI to engage members, how the company thinks about risks, and the importance of monitoring the tools and soliciting feedback.
Trabajar desde casa se ha convertido en algo habitual para muchas personas, pero crear un espacio cómodo y funcional no tiene por qué implicar una gran inversión. La clave está en priorizar lo realmente importante: un equipo fiable, una buena postura, iluminaci& …
Cómo montar un setup de trabajo en casa sin disparar el presupuesto Read More »
El mercado chileno del juego online entra en una nueva fase de desarrollo. La alta conectividad móvil, la adopción generalizada de herramientas de inteligencia artificial y el despliegue de redes 5G comerciales configuran un entorno en el que la personalización, los fo …
El 5G y la IA impulsan los casinos en línea en Chile en 2026 Read More »
Merck and Kelun-Biotech’s antibody-drug conjugate significantly improved progression-free and overall survival in a pivotal endometrial cancer study, though the companies have yet to specify when they plan to file for approval.
Despite having no definitive data, Sen. Ron Johnson (R-WI) in a letter to health secretary Robert F. Kennedy, Jr. suggested there was a conscious effort by the Biden administration’s FDA to cover up the safety risks of COVID-19 vaccines.
FDA’s own report shows no child deaths definitively caused by COVID vaccination Read More »
BioMarin’s investigational therapy failed to elicit clinical improvements in patients with ENPP1 deficiency, while also missing key secondary endpoints of rickets severity and growth.
BioMarin suffers another blow to rare disease portfolio in Phase 3 flop Read More »
